Identification and determination of the urinary metabolite of iodotyrosine in vivo
Our findings suggest that IHPA is detected in larger quantities and may hold more clinical significance than previously identified biomarkers like MIT and DIT, making it a promising candidate for diagnosing congenital hypothyroidism or other conditions associated with iodine recycling inhibition.
Authors
- Pouya Alikhani (ORCID: https://orcid.org/0000-0002-1045-065X)
- José Carlos Moreno varro (ORCID: https://orcid.org/0000-0001-8289-4439)
- Ali R. Mani (ORCID: https://orcid.org/0000-0003-0830-2022)
- Tope Oyelade (ORCID: https://orcid.org/0000-0003-1151-0295)
- Kevin P. Moore
- Danae Zonias
- Ranchu Cheng
- Cindy Xinyu Ji (ORCID: https://orcid.org/0009-0000-1741-9842)
- Nafisa Djumaeva
- Kawther Salim
Institutions
- University College Hospital (GB)
- Hospital Universitario La Paz (ES)
- Hospital La Paz Institute for Health Research (ES)
- University College London (GB)
Publication Details
- Journal
- Biochemical and Biophysical Research Communications
- Published
- 2024-10-20
- DOI
- https://doi.org/10.1016/j.bbrc.2024.150854
- Citations
- 1
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.36